5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zammarchi, Francesca ^a   Boutsalis, George ^a,b   Cartegni, Luca ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TMPRSS2 ERG FUSION PROTEIN; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG; 5' UNTRANSLATED REGION; ERG PROTEIN, HUMAN; ISOPROTEIN; SERINE PROTEINASE; TMPRSS2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ERG GENE; EXON; FUSION GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENE SWITCHING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; OPEN READING FRAME; PROMOTER REGION; PROSTATE CANCER; SIGNAL TRANSDUCTION; TMPRSS2 ERG FUSION GENE; TMPRSS2 GENE; TRANSLATION INITIATION; 3T3 CELL LINE; ALTERNATIVE RNA SPLICING; ANIMAL; CELL DEATH; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; HELA CELL LINE; MALE; METABOLISM; MOUSE; PROSTATE TUMOR; PROTEIN SYNTHESIS; TUMOR CELL LINE;

5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; ANIMALS; CELL DEATH; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HELA CELLS; HUMANS; MALE; MICE; NIH 3T3 CELLS; OPEN READING FRAMES; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; SERINE ENDOPEPTIDASES; TRANS-ACTIVATORS;

EID: 84874602557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049721     Document Type: Article

References (38)

1. Rowley JD, (2001) Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 1: 245-250.
2. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
3. Clark JP, Cooper CS, (2009) ETS gene fusions in prostate cancer. Nat Rev Urol 6: 429-439.
4. Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, et al. (2006) TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66: 3396-3400.
5. Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, et al. (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10: 177-188.
6. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, et al. (2008) Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 68: 73-80.
7. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, et al. (2009) Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41: 619-624.
8. Demichelis F, Fall K, Perner S, Andren O, Schmidt F, et al. (2007) TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 26: 4596-4599.
9. Nam RK, Sugar L, Wang Z, Yang W, Kitching R, et al. (2007) Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 6: 40-45.
10. Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, et al. (2006) TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66: 8337-8341.
11. Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, et al. (2007) Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. J Clin Pathol 60: 1238-1243.
12. Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, et al. (2008) A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci U S A 105: 2105-2110.
13. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, et al. (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol 1: E59.
14. Squire JA, (2009) TMPRSS2-ERG and PTEN loss in prostate cancer. Nat Genet 41: 509-510.
15. Rao VN, Papas TS, Reddy ES, (1987) erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation. Science 237: 635-639.
16. Prasad DD, Rao VN, Lee L, Reddy ES, (1994) Differentially spliced erg-3 product functions as a transcriptional activator. Oncogene 9: 669-673.
17. Duterque-Coquillaud M, Niel C, Plaza S, Stehelin D, (1993) New human erg isoforms generated by alternative splicing are transcriptional activators. Oncogene 8: 1865-1873.
18. Owczarek CM, Portbury KJ, Hardy MP, O'Leary DA, Kudoh J, et al. (2004) Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene 324: 65-77.
19. Wang J, Cai Y, Ren C, Ittmann M, (2006) Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 66: 8347-8351.
20. Clark J, Merson S, Jhavar S, Flohr P, Edwards S, et al. (2007) Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 26: 2667-2673.
21. FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, et al. (2008) Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMC Cancer 8: 230.
22. Jhavar S, Reid A, Clark J, Kote-Jarai Z, Christmas T, et al. (2008) Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn 10: 50-57.
23. Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, et al. (2005) Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24: 3847-3852.
24. Wang J, Cai Y, Yu W, Ren C, Spencer DM, et al. (2008) Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. Cancer Res 68: 8516-8524.
25. Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, et al. (2007) Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Neoplasia 9: 200-206.
26. Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, et al. (2008) TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene 27: 5348-5353.
27. Ghosh AK, Grigorieva I, Steele R, Hoover RG, Ray RB, (1999) PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene 235: 85-91.
28. Mani RS, Iyer MK, Cao Q, Brenner JC, Wang L, et al. (2011) TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. Cancer Res 71: 5387-5392.
29. Kozak M, (2005) Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361: 13-37.
30. McDuff FK, Turner SD, (2011) Jailbreak: oncogene-induced senescence and its evasion. Cell Signal 23: 6-13.
31. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
32. Kozak M, (1991) Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266: 19867-19870.
33. Kochetov AV, Ahmad S, Ivanisenko V, Volkova OA, Kolchanov NA, et al. (2008) uORFs, reinitiation and alternative translation start sites in human mRNAs. FEBS Lett 582: 1293-1297.
34. Calvo SE, Pagliarini DJ, Mootha VK, (2009) Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci U S A 106: 7507-7512.
35. Buttice G, Duterque-Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M, et al. (1996) Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13: 2297-2306.
36. Birdsey GM, Dryden NH, Amsellem V, Gebhardt F, Sahnan K, et al. (2008) Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 111: 3498-3506.
37. Eisen JS, Smith JC, (2008) Controlling morpholino experiments: don't stop making antisense. Development 135: 1735-1743.
38. Moulton JD, Jiang S, (2009) Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14: 1304-1323.